YishengBio seeks greenlight for Hong Kong IPO

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

YishengBio seeks greenlight for Hong Kong IPO

Pharma_drugs_adobe_575x375.jpg
siro46 - stock.adobe.com

China’s YishengBio is planning to list in Hong Kong, having filed an IPO application with the bourse on Monday.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request demo or Login
  • 4,000 annual insights
  • 700+ notes and long-form analyses
  • 4 capital markets databases
  • Daily newsletters across markets and asset classes
  • 2 weekly podcasts
Gift this article